Schedule
Saturday May 24th
Introduction
(10:00-10:10)
10:10-10:45
Psypal: Pioneering EU funded psilocybin therapy for palliative care needs
Ulf Bremberg PhD
​Ulf Bremberg is a distinguished chemist with extensive experience in medicinal chemistry and pharmaceutical research. He earned his Ph.D. in Organic Chemistry from the KTH Royal Institute of Technology in Sweden and subsequently conducted postdoctoral research at the Scripps Research Institute in the United States. ​Currently he is the CEO of the pharmaceutical company Osmond Labs.
​
He has also contributed to academic research as a visiting researcher at Uppsala University's Department of Medicinal Chemistry. In this capacity, he was instrumental in initiating the PsyPal project, a European Union-funded study exploring psychedelic therapy in palliative care.
​
10:45-11:20
Psilocybin assisted therapy as a treatment for cancer-related depression
Evana Lopez MD
Evana López is the study physician for the CAPSI research project and Ph.D. student in Johan Lundbergs research group at Karolinska institutet. She has a particular interest in uncovering the mechanism of action behind the psychedelic therapeutic effect as well as broadening the understanding of altered states of consciousness.
Lunch
(11:20-12:20)
12:20-13:05
Feasibility of Psilocybin as a treatment for Anorexia Nervosa
Kate Godfrey PhD
Dr. Kate Godfrey completed her PhD in pharmacy at the University of Auckland, New Zealand, where she investigated neurological correlates of antidepressant response to brain stimulation treatment. Following this, she moved to the Centre for Psychedelic Research at Imperial College London, where she has been leading the implementation of EEG to study the effects of psychedelics on the brain across multiple studies within the centre. She has particular interest in the use of psychedelics as treatment for mental health conditions and developing electrophysiological measures of neuroplasticity for use in psychedelic research.
13:05-13:40
Ketamine for depression in Swedish Healthcare:
Approaches and implementation
Alexandra Leinonen MD
Carl Enholm MSc in Psychology & Co-Founder of UPV
Alexandra Leinonen is a ST doctor in Skaraborg Psychiatry where she leads ketamine therapy for severe and treatment resistant depression. In 2024 she started her PhD where she is investigating how to potentially make the treatment safer and more effective using psychosocial interventions.
​
​Carl Enholm is the co-founder of UPV. He is especially interested in the role of subjective effects in psychedelic therapy, researching the implementation of the Montreal model of ketamine therapy in Swedish healthcare.
Fika
(13:40-14:00)
14:00-14:35
Thoughts on developing a course on psychedelics for clinical psychology students
Christopher Sundström PhD
Christopher Sundström is a licensed psychologist, lecturer at Uppsala University and researcher at both Uppsala University and Karolinska Institutet. Christoffer focuses mainly on addiction research, investigating the potential of internet based interventions for alcohol use disorder. This spring he was tasked with developing and teaching Uppsala Universitys first ever course in Psychedelics.
14:35-15:10
NPV Essay Prize
Winner to be announced
The Swedish Network for psychedelic science works to further research within the field. To encourage research and promote a more open academic climate, a prize is awarded annually for the best essay related to psychedelic science. NPV will announce the winner of the 2024 essay prize, who will get a chance to present their award winning work.
​
Fika
(15:10-15:30)
15:30-16:05
Personality, Genetics and the Psychedelic Experience
Petri Kajonius, PhD
Petri Kajonius is a Docent and personality researcher at Lund University. He has done research in various areas of personality like Dark Triad personality traits, well-being, and behavioral genetics. In the psychedelic field he has researched the link between personality and psychedelic experiences as well as exploring the meaningfulness of psychedelic experiences.
​
Petri has also co-authored several books, among these the most recent one being "High on life - the modern psychedelic research".
16:05-16:55
Implementing Psychedelic Treatments:
Carving out the path forward
Panel discussion
Ulf Bremberg will moderate a panel discussion with a variety of different experts in the psychedelic field. They will adress important questions, discuss possible solutions and open up for questions from the audience.
Conclusion & Mingling
17:00-17:30